The import of streptomycins into the US is projected to grow from $36.427 million in 2024 to $43.569 million by 2028. The actual value in 2023 was lower, marking the beginning of this upward trend. Year-on-year comparisons reveal a steady increase, with percentage growth gradually climbing from 5% to 8% each year. Over the five-year period from 2024 to 2028, the compound annual growth rate (CAGR) stands at approximately 4.51%, indicating consistent demand and market expansion for streptomycins.

Future Trends to Watch:

Regulatory changes that may affect import duties or restrictions.
Technological advances in antibiotics production that could affect market dynamics.
Shifts in global supply chains impacting availability and costs.